USPTO serial 88018527
ROCKETSCRIPT
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Dec 24, 2019
- Examiner
- BAKER, JORDAN A
- Law office
- Historical data usage
What this means
Status 701 means the registration is active and the first Section 8 declaration of continued use was accepted. The next major deadline is the combined Section 8 and Section 9 filing at the 10-year anniversary. Calendar the 10-year Section 8 and 9 combined renewal.
Need help with ROCKETSCRIPT?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Steven J. Hultquist
Steven J. Hultquist HULTQUIST, PLLCPO BOX 14329RESEARCH TRIANGLE PARK, NC 27709United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | biological enzymes for non-medical use; compositions for use in cDNA synthesis for research purposes; kits for use in cDNA synthesis for research purposes comprised of reagents, buffers, reverse transcriptase, oligomer; compositions for use in nucleic acid fluorescence staining for research purposes; kits for use in nucleic acid fluorescence staining for research purposes consisting of reagents, buffers, staining reagents; compositions for use in DNA sequence analysis for research purposes; kits for use in DNA sequence analysis for research purposes consisting of reagents, buffers, DNA polymerase; nucleic acid polymerase for research purposes; compositions for use in nucleic acid amplification for research purposes; kits for use in nucleic acid amplification for research purposes consisting of reagents, buffers, nucleic acid polymerase; chemical reagents for research purposes; compositions for use in polymerase chain reaction for research purposes; compositions for use in reverse transcription for research purposes | ACTIVE | — |
| 005 | biological enzymes for medical use; kits for use in cDNA synthesis for medical purposes comprised of reagents, buffers, reverse transcriptase, oligomer; compositions for use in nucleic acid fluorescence staining for medical purposes; kits for use in nucleic acid fluorescence staining for medical purposes consisting of reagents, buffers, staining reagents; compositions for use in DNA sequence analysis for medical purposes; kits for use in DNA sequence analysis for medical purposes consisting of reagents, buffers, DNA polymerase; nucleic acid polymerase for medical purposes; compositions for use in nucleic acid amplification for medical purposes; kits for use in nucleic acid amplification for medical purposes consisting of reagents, buffers, nucleic acid polymerase; chemical reagents for medical purposes; compositions for use in nucleic acid amplification for medical purposes; compositions for use in reverse transcription for medical purposes | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by BIONEER CORPORATION
- Other trademarks owned by BIONEER CORPORATION
- Other trademarks owned by BIONEER CORPORATION
- Other trademarks in Class 001
- Other trademarks in Class 005
- Similar marks named ROCKETSCRIPT
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 5, 2025 | NAS8 | NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED | — |
| Jun 5, 2025 | 8.OK | REGISTERED - SEC. 8 (6-YR) ACCEPTED | The USPTO accepted your Section 8 declaration showing the mark is still in use in commerce (or excusable nonuse). This satisfies the six-year maintenance requirement and keeps the registration active until the next renewal deadline. |
| May 26, 2025 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Jan 14, 2025 | ES8R | TEAS SECTION 8 RECEIVED | — |
| Dec 24, 2024 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Dec 24, 2019 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 8, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 8, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 18, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 3, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 30, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 30, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 29, 2019 | ALIE | ASSIGNED TO LIE | — |
| Aug 23, 2019 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Apr 24, 2019 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Apr 24, 2019 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Apr 24, 2019 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Oct 22, 2018 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Oct 22, 2018 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Oct 22, 2018 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Oct 19, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 3, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 2, 2018 | NWAP | NEW APPLICATION ENTERED | — |